tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ASKA Pharmaceutical Opposes Shareholder Proposal, Emphasizes Growth Strategy
Company AnnouncementsASKA Pharmaceutical Opposes Shareholder Proposal, Emphasizes Growth Strategy
1M ago
4886
ASKA Pharmaceutical Reports FY2024 Financial Results with Strategic Dividend Increase
PremiumCompany Announcements
ASKA Pharmaceutical Reports FY2024 Financial Results with Strategic Dividend Increase
1M ago
4886
ASKA Pharmaceutical Opposes Shareholder Proposal, Focuses on Growth Strategy
PremiumCompany Announcements
ASKA Pharmaceutical Opposes Shareholder Proposal, Focuses on Growth Strategy
1M ago
4886
ASKA Pharmaceutical Reports Strong Sales and Positive Outlook for FY2025
PremiumCompany Announcements
ASKA Pharmaceutical Reports Strong Sales and Positive Outlook for FY2025
1M ago
4886
ASKA Pharmaceutical Announces Increased Dividend Payout
PremiumCompany Announcements
ASKA Pharmaceutical Announces Increased Dividend Payout
1M ago
4886
ASKA Pharmaceutical Reports FY2024 Financial Results with Increased Dividends
PremiumCompany AnnouncementsASKA Pharmaceutical Reports FY2024 Financial Results with Increased Dividends
1M ago
4886
ASKA Pharmaceutical Announces Leadership Changes to Drive Future Growth
Premium
Company Announcements
ASKA Pharmaceutical Announces Leadership Changes to Drive Future Growth
2M ago
4886
ASKA Pharmaceutical Recognized for Dual-career and Co-parenting Support
Premium
Company Announcements
ASKA Pharmaceutical Recognized for Dual-career and Co-parenting Support
3M ago
4886
ASKA Pharmaceutical to Cancel 1.8 Million Treasury Shares
PremiumCompany Announcements
ASKA Pharmaceutical to Cancel 1.8 Million Treasury Shares
3M ago
4886
ASKA Pharmaceutical Holdings Recognized for Health Management Excellence
PremiumCompany Announcements
ASKA Pharmaceutical Holdings Recognized for Health Management Excellence
3M ago
4886
ASKA Launches Clinical Trial for New Gynecological Drug in Japan
PremiumCompany Announcements
ASKA Launches Clinical Trial for New Gynecological Drug in Japan
4M ago
4886
ASKA Pharmaceutical Expands Southeast Asia Presence Through Strategic Collaboration
PremiumCompany Announcements
ASKA Pharmaceutical Expands Southeast Asia Presence Through Strategic Collaboration
4M ago
4886
ASKA Pharmaceutical Announces Key Personnel Changes
PremiumCompany AnnouncementsASKA Pharmaceutical Announces Key Personnel Changes
4M ago
4886
ASKA Pharmaceutical Announces Key Organizational Changes
Premium
Company Announcements
ASKA Pharmaceutical Announces Key Organizational Changes
4M ago
4886
ASKA Pharmaceutical Achieves Record Sales Amidst Rising R&D Costs
Premium
Company Announcements
ASKA Pharmaceutical Achieves Record Sales Amidst Rising R&D Costs
5M ago
4886
ASKA Pharmaceutical Announces Third Quarter FY2024 Financial Results
PremiumCompany Announcements
ASKA Pharmaceutical Announces Third Quarter FY2024 Financial Results
5M ago
4886
ASKA Pharmaceutical Expands Southeast Asian Presence with Hataphar Acquisition
PremiumCompany Announcements
ASKA Pharmaceutical Expands Southeast Asian Presence with Hataphar Acquisition
5M ago
4886

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >